Behavioral considerations for engaging youth in HIV clinical research

Journal of Acquired Immune Deficiency Syndromes

Volumn 54, Issue SUPPL. 1, 2010, Pages

  Hosek, Sybil G ^a   Zimet, Gregory D ^b  

^a Jr Hospital of Cook County   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

adolescents; clinical trials; HIV AIDS; recruitment; sexual behavior

Indexed keywords

ADOLESCENT; CHILD BEHAVIOR; CLINICAL RESEARCH; CLINICAL TRIAL; COGNITION; COGNITIVE DEVELOPMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RATE; INTERVENTION STUDY; NEUROPHYSIOLOGY; PREVENTION STUDY; PRIORITY JOURNAL; PSYCHOSOCIAL DEVELOPMENT; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SEXUAL BEHAVIOR;

ADOLESCENT; ADOLESCENT BEHAVIOR; ADOLESCENT DEVELOPMENT; BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; HIV INFECTIONS; HUMANS; INFORMED CONSENT; RISK FACTORS; RISK-TAKING; YOUNG ADULT;

EID: 77954079088     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181e15c22     Document Type: Review

References (70)

1. Centers for Disease Control and Prevention (CDC). HIV/AIDS Surveillance Report, 2008. Atlanta, GA: US Department of Health and Human Services (USDHHS), CDC.
2. Centers for Disease Control and Prevention (CDC). Youth Risk Behavior Surveillance\United States, 2007. MMWR Surveill Summ. 2008;57: 1-131.
3. Erikson EH. Childhood and Society. New York, NY: Norton; 1950.
4. Arnett JJ. Emerging adulthood: a theory of development from the late teens through the twenties. Am Psychol. 2000;55:469-480.
5. Arnett JJ. Reckless behavior in adolescence: a developmental perspective. Dev Rev. 1992;12:339-373.
6. Hosek SG, Harper GW, Domanico R. Psychological predictors of medication adherence among HIV-infected youth. Psychol Health Med. 2005;10:166-179.
7. Casey BJ, Galvan A, Hare TA. Changes in cerebral functional organization during cognitive development. Curr Opin Neurobiol. 2005;15: 239-244.
8. Casey BJ, Thomas KM, Davidson MC, et al. Dissociating striatal and hippocampal function developmentally with a stimulus-response compatibility task. J Neurosci. 2002;22:8647-8652.
9. Casey BJ, Giedd JN, Thomas KM. Structural and functional brain development and its relation to cognitive development. Biol Psychol. 2000;54:241-257.
10. Casey BJ, Jones RM, Hare TA. The adolescent brain. Ann NY Acad Sci. 2008;1124:111-126.
11. Galvan A, Hare TA, Parra CE, et al. Earlier development of the accumbens relative to orbitofrontal cortex might underlie risk-taking behavior in adolescents. J Neurosci. 2006;26:6885-6892.
12. Adams GR, Gullotta TP, Montemayor R. Adolescent Identity Formation. Newbury Park, CA: Sage; 1992.
13. Erikson EH. Identity: Youth and Crisis. New York, NY: Norton; 1968.
14. Valde GA. Identity closure: a fifth identity status. J Genet Psychol. 1996; 157:245-254.
15. Waterman AL. Identity development from adolescence to adulthood: an extension of theory and a review of research. Dev Psychol. 1982;18: 341-358.
16. Arnett JJ. Sensation seeking: a new conceptualization and a new scale. Pers Individ Dif. 1994;16:289-296.
17. Joyner K Udry JR. You don't bring me anything but down: adolescent romance and depression. J Health Soc Behav. 2000;41:369-391.
18. Graber JA, Seeley JR, Brooks-Gunn J, et al. Is pubertal timing associated with psychopathology in young adulthood. J Am Acad Child Adolesc Psychiatry. 2004;43:718-726.
19. Swarts L, Kagee A, Kafaar Z, et al. Social and behavioral aspects of child and adolescent participation in HIV vaccine trials. J Int Assoc Physicians AIDS Care 2005;4:89-92.
20. Flisher AJ, Chalton DO. Adolescent contraceptive non-use and covariation among risk behaviors. J Adolesc Health. 2001;28:235-241.
21. Brooks-Gunn J, Graber JA. What's sex got to do with it? The development of sexual identities during adolescence. In: Contrada RJ, Ashmore RD, eds. Self, Social Identity and Physical Health 1999. New York, NY: Oxford University Press;1999.
22. O'Connor TG, Allen JP, Bell KL, et al. Adolescent-parent relationships and leaving home in young adulthood. New Dir Child Dev. 1996;71:39-52.
23. Hoff T, Greene L, Davis J. National Survey of Adolescents and Young Adults: Sexual Health Knowledge, Attitudes and Experiences. Menlo Park, CA: Kaiser Family Foundation; 2003.
24. Brady SS, Tschann JM, Ellen JM, et al. Infidelity, trust and condom use among Latino youth in dating relationships. Sex Transm Dis. 2009;36: 227-231.
25. Senn TE, Carey MP, Vanable PA, et al. Sexual partner concurrency among STI clinic patients with a steady partner: correlates and associations with condom use. Sex Transm Infect. 2009;85:343-347.
26. Lenoir CD, Adler NE, Borzekowski DL, et al. What you don't know can hurt you: perceptions of sex-partner concurrency and partner-reported behavior. Journal of Adol Health. 2006;38:179-185.
27. Wilde GJS. The theory of risk homeostasis: Implications for safety and health. Risk Anal. 1982;2:209-225.
28. Wilde GJS. Risk homeostasis theory: an overview. Inj Prev. 1998;4:89-91.
29. O'Neill B, Williams A. Risk homeostasis hypothesis: a rebuttal. Inj Prev. 1998;4:92-93.
30. Pless IB, Magdalinos H, Hagel B. Risk-compensation behavior in children: myth or reality? Arch Pediatr Adolesc Med. 2006;160:610-614.
31. Pinkerton SD. Sexual risk compensation and HIV/STD transmission: empirical evidence and theoretical considerations. Risk Anal. 2001;21: 727-736.
32. Webb PM, Zimet GD, Mays RM, et al. HIV immunization: acceptability and anticipated effects on sexual behavior among adolescents. J Adolesc Health. 1999;25:320-322.
33. Newman PA, Lee S-J, Duan N, et al. Preventive HIV vaccine acceptability and behavioral risk compensation among a random sample of high-risk adults in Los Angeles (LA VOICES). Health Serv Res. 2009;44: 2167-2179.
34. Cassell MM, Halperin DT, Shelton JD, et al. Risk compensation: the Achilles' heel of innovations in HIV prevention. BMJ. 2006;332:605-607.
35. Eaton LA, Kalichman SC. Risk compensation in HIV prevention: Implications for vaccines, microbicides, and other biomedical HIV prevention technologies. Curr HIV/AIDS Rep. 2007;4:165-172.
36. Zimet GD, Shew ML, Kahn JA. Appropriate use of cervical cancer vaccine. Ann Rev Med. 2008;59:223-236.
37. Simon AE, Wu AW, Lavori PW, et al. Preventive misconception: its nature, presence, and ethical implications for research. Am J Prev Med. 2007;32:370-374.
38. Mantell JE, Morar NS, Myer L, et al. "We have our protector": misperceptions of protection against HIV among participants in a micro-bicide efficacy trial. Am J Public Health. 2006;96:1073-1077.
39. Luchters S, Chersich MF, Jao I, et al. Acceptability of the diaphragm in Mombasa Kenya: a 6-month prospective study. Eur J Contracep Repr Health Care. 2007;12:345-352.
40. Guest G, Johnson L, Burke H, et al. Changes in sexual behavior during a safety and feasibility trial of a microbicide/diaphragm combination: an integrated qualitative and quantitative analysis. AIDS Educ Prev. 2007;19: 310-320.
41. Behets FMTF, Van Damme K, Turner AN, et al. Evidence-based planning of a randomized controlled trial on diaphram use for prevention of sexually transmitted infections. Sex Transm Dis. 2008;35:238-242.
42. Hollander JA. The social context of focus groups. Contemp Ethnog. 2004; 33:602-637.
43. Padian NS, van der Straten A, Ramjee G, et al, and MIRA Team. Diaphragm and lubricant gel for prevention of HIVacquisition in southern African women: a randomised controlled trial. Lancet. 2007;370: 251-261.
44. Chesney MA, Chambers DB, Kahn JO. Risk behavior for HIV infection in participants in preventive HIV vaccine trials: A cautionary note. J Acquir Immune Defic Syndr Human Retrovirol. 1997;16:266-271.
45. Macqueen KM, Buchbinder S, Douglas JM, et al. The decision to enroll in HIV vaccine efficacy trials: Concerns elicited from gay men at increased risk for HIV infection. AIDS Res Human Retroviruses. 1994;10:S261-S264.
46. Colfax G, Buchbinder S, Vamshidar G, et al. Motivations for participating in an HIV vaccine efficacy trial. J Acquir Immune Defic Syndr. 2005;39: 359-364.
47. Johnson MO. Belief of vaccine receipt in HIV vaccine trials: Further cautions. J Acquir Immune Defic Syndr. 1999;21:413-416.
48. Bartholow BN, Buchbinder S, Celum C, et al. HIV sexual risk behavior over 36 months of follow-up in the world's first HIV vaccine efficacy trial. J Acquir Immune Defic Syndr. 2005;39:90-101.
49. van Griensven F, Keawkungwal J, Tappero JW, et al. Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX B/E HIV vaccine trial in Bangkok, Thailand. AIDS. 2004;18: 295-301.
50. Lampinen JM, Chan K, Remis RS, et al. Sexual risk behaviour of Canadian participants in the first efficacy trial of a preventive HIV-1 vaccine. Can Med Assoc J. 2005;172:479-483.
51. Strauss RP, Sengupta S, Kegeles S, et al. Willingness to volunteer in future preventive HIV vaccine trials: issues and perspectives from three U.S. communities. J Acquir Immune Defic Syndr. 2001;26:63-71.
52. McGrath JW, George K, Svilar G, et al. Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in Ugandan military. J Acquir Immune Defic Syndr. 2001;27:381-388.
53. DeSouza CTV, Lowndes CM, Szwarcwald CL, et al. Willingness to participate in HIV vaccine trials among a sample of men who have sex with men, with and without a history of commercial sex, Rio de Janeiro, Brazil. AIDS Care. 2003;15:539-548.
54. Suhadev M, Nyamathi AM, Swaminathan S, et al. A pilot study on willingness to participate in future preventive HIV vaccine trials. Indian J Med Res. 2006;124:631-640.
55. Newman PA, Duan N, Roberts KJ, et al. HIV vaccine trial participation among ethnic minority communities: Barriers, motivator, and implications for recruitment. J Acquir Immune Defic Syndr. 2006;41:210-217.
56. Schuklenk U, Ashcroft R. HIV vaccine trials: reconsidering the therapeutic misconception and the question of what constitutes trial related injuries. Dev World Bioeth. 2007;7:ii-iv.
57. Appelbaum PS, Roth LH, Lidz CW, et al. False hopes and best data: consent to research and the therapeutic misconception. Hastings Cent Rep. 1987;172:20-24.
58. Appelbaum PS, Lidz CW, Grisso T. Therapeutic misconception in clinical research: frequency and risk factors. IRB. 2004;26:1-8.
59. Kafaar Z, Swartz L, Kagee A, et al. Adolescent participation in HIV vaccine trials: cognitive developmental considerations. S Afr J Psychol. 2007;37:576-594.
60. Flory J, Emanuel E. Interventions to improve research participants' understanding in informed consent for research: a systematic review. JAMA. 2004;292:1593-1601.
61. Robinson EJ, Kerr CEP, Stevens AJ, et al. Lay public's understanding of equipoise and randomisation in randomised controlled trials. Health Technol Asses. 2005;9:1-192.
62. Murphy DA, Hoffman D, Seage III GR, et al, and The Adolescent Trials Network for HIV/AIDS Interventions. Improving comprehension for HIV vaccine trial information among adolescents at risk of HIV. AIDS Care. 2007;19:42-51.
63. Lyles CM, Kay LS, Crepaz N, et al. Best-evidence interventions: findings from a systematic review of HIV behavioral interventions for US populations at high risk, 2000-2004. Am J Public Health. 2007;97: 133-143. (Pubitemid 46067695)
64. Smith SR, Brock TP, Howarth SM. Use of Personal Digital Assistants to deliver education about adherence to antiretroviral medications. J Am Pharm Assoc. 2005;45:625-628.
65. Puccio JA, Belzer M, Olson J, et al. The use of cell phone reminder calls for assisting HIV-infected adolescents and young adults to adhere to highly active antiretroviral therapy: a pilot study. AIDS Patient Care STDS. 2006;20:438-444.
66. Curioso WH, Kurth AE. Access, use and perceptions regarding internet, cell phones and PDAs as a means for health promotion for people living with HIV in Peru. BMC Med Inform Decis Mak. 2007;7:24.
67. Curioso WH, Kurth AE, Cabello R, et al. Usability evaluation of Personal Digital Assistants (PDAs) to support HIV treatment adherence and safer sex behavior in Peru. AMIA Annu Symp Proc. 2008;918.
68. Cornelius JB, St. Lawrence JS. Receptivity of African American adolecents to an HIV-prevention curriculum enhanced by test messaging. J Spec Pediatr Nurs. 2009;14:123-131.
69. Short MB, Black W, Zimet GD, et al. Enrollment of young adolescents in a microbicide acceptability study. Sex Trans Infect. 2010;86:71-73.
70. Office of Human Subjects Research. The Belmont report: ethical principles and guidelines for the protection of human subjects research. Available at: http://ohsr.od.nih.gov/guidelines/belmont.html. Accessed January 29, 2010.